hypertension
Conditions
Interventions
control group:Health Education
Treatment group:Health Education
control group:Received 6.5 g compound Guizhencao simulant, twice daily,for four weeks.
Treatment group:Received 6.5 g compound Guizhencao granule, twice daily,for four weeks.
Sponsors
The First Affiliated Hospital of Henan University of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Meet the grade I diagnostic criteria of hypertension, and the risk stratification is low-risk or medium-risk; (2) Not taking antihypertensive drugs in the past or taking antihypertensive drugs regularly; (3) Between 35-55 years old; (4) Agree to sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with hypertension grade II or above; (2) Hypertensive patients with severe target organ damage of liver, kidney, heart and brain; (3) Allergic constitution, or allergic to a variety of drugs and food; (4) Women who have pregnancy plans or are pregnant or lactating; (5) Patients who cannot take care of themselves or oral drugs; (6) Participate in other clinical researchers within one month; (7) Suspected or true history of alcohol and drug abuse; Or the study believes that there are patients with inappropriate inclusion factors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM syndrome score;24-hour ambulatory blood pressure;Metabonomics test; | — |
Secondary
| Measure | Time frame |
|---|---|
| electrolyte;interleukin 6,IL-6;urinalysis;Endothelin-1;Routine blood test;Interleukin-1ß;Renal function;catecholamine;Tumor necrosis factor-a;liver function; | — |
Countries
China
Contacts
Public ContactLi bin
Outcome results
None listed